article thumbnail

California’s low-cost insulin plans receive $100m manufacturing boost

Pharmaceutical Technology

Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. In-house manufacturing the norm.

Insulin 328
article thumbnail

Key senators make a big pivot on bipartisan insulin cost proposal

STAT News

WASHINGTON — Amid a scramble to assemble a health care policy package in the Senate, a pair of key senators have significantly changed a proposal to cap insulin costs. The new legislation by Senate Diabetes Caucus co-chairs Sens. Jeanne Shaheen (D-N.H.) Jeanne Shaheen (D-N.H.) Read the rest…

Insulin 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Amid GLP-1 boom, Novo Nordisk strikes up insulin partnership in Indonesia

Fierce Pharma

While much of the attention on Novo Nordisk these days revolves around the company’s wildly popular GLP-1 drugs Ozempic and Wegovy, insulin remains a critical backbone for the drugmaker. |

Insulin 85
article thumbnail

Roche debuts smart glucose monitor for hospital use

pharmaphorum

” The Android-powered device can run certified third-party software, initially shipping with a handful of apps including Glytec’s Glucommander insulin-dosing software under the terms of a deal announced today.

Insulin 128
article thumbnail

Sanofi to Invest €40M to Expand Production of Thymoglobulin and Diabetes Drug Tzield at France Site

XTalks

million) of the investment package will go towards internalizing and localizing the production of monoclonal antibodies for Tzield in France. billion) insulin manufacturing facility at its Frankfurt Höchst campus in Germany. In a news release (in French) announcing the investment, Sanofi shared that €25 million ($26.54 billion ($1.38

article thumbnail

This is the Newest Functional Beverage from the Co-Founders of Oatly and Fiji Water

XTalks

While the line was initially launched in 2018 under the name “The Swedish Sugar Buster,” the re-launch features new packaging and flavors that are more suitable for today’s functional beverage market. However, none of these claims have been evaluated by the US Food and Drug Administration (FDA).

article thumbnail

MIOTIFY platform for digital health products clears AZ road test

pharmaphorum

UK company MIOTIFY has developed a web-based software platform that product teams can use to configure medical algorithms quickly, create code packages to harness them and generate supporting documentation – all in a format that is designed to meet regulatory requirements for software as a medical device (SaMD). Sheena Macpherson.